Login to Your Account



Pharma: Other News To Note


Thursday, October 11, 2012
• Almirall SA, of Barcelona, Spain, said it granted Invida Holdings Private Ltd., part of the Menarini Group, of Florence, Italy, the commercial rights for Aclidinium, a long-acting inhaled muscarinic antagonist, in Australia and New Zealand, for chronic obstructive pulmonary disorder.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription